389P Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial
Han Li(Hebei Medical University), Zhi Shi(University of Jinan), G. ren(Shandong First Medical University), Shujuan Sun(Shandong First Medical University), Z. Yv(Binzhou Medical University), Binkui Li(Sun Yat-sen University), Biao Fan(Shandong Tumor Hospital), Lingling Wang(SLAC National Accelerator Laboratory), Zhan Wang(First Affiliated Hospital of Zhengzhou University), Xuan Zhao(People's Hospital of Xinjiang Uygur Autonomous Region), Weiling Li(Shandong University), Jie Huang(Shandong First Medical University), Dongdong Zhou(Shandong Tumor Hospital), Haiying Fu(Jilin University), Xiu‐Lan Sun(Nanjing University of Chinese Medicine), Shu Fang(Peking University), Yiqiu Liao(Nanchang University)
Cited by 0
Related Papers
Antagonizing peroxisome proliferator‐activated receptor γ facilitates M1‐to‐M2 shift of microglia by enhancing autophagy via the <scp>LKB</scp>1–<scp>AMPK</scp> signaling pathway
|Aging Cell|2018|213
Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes
|Molecular and Cellular Neuroscience|2006|181
Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain
|Neuroscience Letters|2010|178
Desensitized nicotinic receptors in brain
|Brain Research Reviews|2004|175
Neuroprotective effects of berberine on stroke models in vitro and in vivo
|Neuroscience Letters|2008|169